Form 4 for BBLG Bone Biologics Corp
Accepted 2023-09-05 00:00:00 ET · period of report 2023-08-31 · accession 0001493152-23-031680 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-05 | 2023-08-31 | BBLG | Frelick Jeff | CEO | P - Purchase | $0.66 | +7,600 | 7,704 | +7,308% | +$5,016 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-31 | P | A | 7,600 | $0.66 | 7,704 | D | — | — | (F1) Includes 104 shares of vested restricted stock that were inadvertently reported in Table II at the time of grant. |